D
Arcutis Biotherapeutics, Inc. ARQT
$16.16 -$0.44-2.65%
Recommendation
Sell
Prev Close
$16.60
Volume
2,758,016
Avg Vol (90D)
2,275,558
Market Cap
$1.97B
Dividend & Yield
--
52-Week Range
$6.99 - $17.75
P/E (TTM)
--
EPS (TTM)
-$1.16
My Lists My Alerts
Rating
Reward
E
Very Weak
Risk
D
Weak
Rating Factors
Growth Index
Good
Efficiency Index
Very Weak
Solvency Index
Excellent
Total Return Index
Fair
Volatility Index
Weak
Dividend Index
--
Headlines
Arcutis Biotherapeutics (ARQT) Moves 10.8% Higher: Will This Strength Last?
4/3/2025 - Zacks Investment Research
Demystifying Arcutis Biotherapeutics: Insights From 9 Analyst Reviews
4/3/2025 - Benzinga
Arcutis Biotherapeutics (ARQT, $16.6) Stochastic Oscillator left the oversold zone on April 02, 2025
4/3/2025 - Tickeron - Stocks
Arcutis Biotherapeutics (ARQT, $16.6) Aroon Indicator entered an Uptrend on April 02, 2025.
4/3/2025 - Tickeron - Stocks
Arcutis Biotherapeutics (ARQT, $16.6) entered Uptrend as Momentum indicator ascends above 0 level on Apr 02, 2025
4/3/2025 - Tickeron - Stocks
Arcutis Biotherapeutics (ARQT) Shares Rise Amid Patent Lawsuit Pause
4/2/2025 - GuruFocus
Arcutis Biotherapeutics, Padagis agree to stay patent lawsuit
4/2/2025 - The Fly
Arcutis and Padagis Agree to Stay Patent Lawsuit
4/2/2025 - Globe Newswire
Arcutis Biotherapeutics (ARQT, $14.98) Stochastic Oscillator left the oversold zone on April 01, 2025
4/2/2025 - Tickeron - Stocks
Arcutis Biotherapeutics (ARQT, $14.98) Aroon Indicator entered an Uptrend on April 01, 2025.
4/2/2025 - Tickeron - Stocks
Arcutis Biotherapeutics (ARQT, $15.64) entered Downtrend as Momentum indicator drops below 0 level on Mar 31, 2025
4/1/2025 - Tickeron - Stocks
Arcutis Biotherapeutics (ARQT, $15.64) Aroon Indicator entered an Uptrend on March 31, 2025.
4/1/2025 - Tickeron - Stocks
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Sees Large Drop in Short Interest
4/1/2025 - MarketBeat
Prudential Financial Inc. Has $8.25 Million Holdings in Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT)
3/31/2025 - MarketBeat
Arcutis Biotherapeutics (ARQT, $15.73) Aroon Indicator entered an Uptrend on March 28, 2025.
3/29/2025 - Tickeron - Technical Analysis
Arcutis Biotherapeutics (ARQT, $15.73) Moving Average Convergence Divergence (MACD) Histogram turned negative on March 28, 2025
3/29/2025 - Tickeron - Technical Analysis
How Much Upside is Left in Arcutis Biotherapeutics (ARQT)? Wall Street Analysts Think 25.85%
3/28/2025 - Zacks Investment Research
Are Medical Stocks Lagging Cardinal Health (CAH) This Year?
3/28/2025 - Zacks Investment Research
Why IBD 50's Arcutis Is Outplaying The Biotech Tape And Sprinting Toward A Profit-Taking Zone
3/28/2025 - Investor's Business Daily
Arcutis Biotherapeutics (ARQT, $16.09) Aroon Indicator entered an Uptrend on March 27, 2025.
3/28/2025 - Tickeron - Stocks
Arcutis Biotherapeutics (ARQT, $16.09) Stochastic Oscillator left the overbought zone on March 27, 2025
3/28/2025 - Tickeron - Stocks
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Insider Todd Franklin Watanabe Sells 1,500 Shares
3/27/2025 - MarketBeat
Arcutis Biotherapeutics Inc (ARQT) to Participate in 24th Annual Needham Virtual Healthcare ...
3/27/2025 - GuruFocus
Arcutis to Present at the 24th Annual Needham Virtual Healthcare Conference
3/27/2025 - Globe Newswire
Arcutis Biotherapeutics, Inc. (NASDAQ:ARQT) Insider Sells $26,280.00 in Stock
3/27/2025 - MarketBeat
Income Statement
Total Revenue (TTM)
$196.54M
EBITDA (TTM)
-$125.80M
EBIT (TTM)
-$128.40M
Net Income (TTM)
-$140.04M
Balance Sheet
Total Assets (Q)
$348.89M
Total Debt (Q)
$110.59M
Total Liabilities (Q)
$191.35M
Book Value Per Share (Q)
$1.34
Cash Flow
Cash from Operations (TTM)
-$112.16M
Cash from Investing (TTM)
$28.82M
Cash from Financing (TTM)
$66.20M
Net Change in Cash (TTM)
-$17.37M
Filings
Filing Date
Tuesday, February 25, 2025
Period Date
Tuesday, December 31, 2024
Next Filing
Week of May 12 and 16 (est)
Price History
Loading...
Beta
2.00
7-Day Total Return
-5.55%
30-Day Total Return
20.42%
60-Day Total Return
9.86%
90-Day Total Return
58.74%
Year to Date Total Return
10.99%
1-Year Total Return
67.81%
2-Year Total Return
44.93%
3-Year Total Return
-24.31%
5-Year Total Return
-36.25%
52-week Low
Jun 10, 2024 - $6.99
52-week High
Mar 25, 2025 - $17.75
Valuation
Market Cap
$1.97B - Small Cap
Enterprise Value
$1.85B
Price/Sales (TTM)
10.55
Price/Book (Q)
12.42
Dividends and Shares
Shares Outstanding
124.92M
Dividend Per Share (Most Recent)
--
Dividend Per Share (TTM)
--
Corporate Info
Website
www.arcutis.com
Phone Number
805 418 5006
Address
3027 Townsgate Road
Westlake Village, CA 91361
Country
United States
Year Founded
2016
Business Description
Sector
Health Care
Industry
Pharmaceuticals, Biotechnology and Life Sciences
Arcutis Biotherapeutics, Inc., a biopharmaceutical company, focuses on developing and commercializing treatments for dermatological diseases. Its lead product is ZORYVE, a topical roflumilast... more
NASDAQ 04/03/2025 4:00PM Eastern Quotes delayed
Weiss Ratings